<<AEZS may initiate a second Colon Cancer phase III after completing the analysis of first phase III>> see linkhttp://www.rttnews.com/1852599/aeterna-zentaris-phase3-perifosine-trial-fails-to-meet-primary-endpoint.aspx<<Aeterna Zentaris said it is very disappointed at Colon cancer phase III result. The company will continue further data analyses in collaboration with our licensee partners, in order to determine the future development strategy for perifosine.>>
tell me something we don't already know. Next think you're going to tell us that Perifosine may work in Multiple Myeloma. This is old news the Yakult will continue with the CRC trials but we haven't heard anything from them.